|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial显示文摘 | GHEORGHIADE M GA337S WA O'CONNOR CM | 2004 | JAMA2004，291，16： | 1 |
| 2 | Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure:results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure(IMPACT-I-IF) trial显示文摘 | Gattis WA O'Connor CM Gallup DS | 2004 | JAM Coll Cardiol2004，43，： | 1 |
| 3 | Synthesis and biological evaluation of 5- methylene] oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with anti-inflammatory activity 显示文摘 | Unangst PC Connor DT Cetenko WA | 1994 | J Med Chem1994，37，2： | 1 |
| 4 | Implications of elevated cardiac troponin T in ambulatory patients with heart failure:a prospective analysis显示文摘 | O'Connor CM Gattis WA | 2004 | Am Heart J2004，147，3： | 1 |
| 5 | Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure显示文摘 | Gattis WA O'Connor CM Leimberger JD | 2003 | Am J Cardiol2003，91，： | 1 |
| 6 | Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function显示文摘 | O'Connor CM Gattis WA Shaw L | 2000 | Am J Cardiol2000，86，8： | 1 |
| 7 | Effects of tolvaptan,a vasopressin antagonist,in patients hospitalized with worsening heart failure:a randomized controlled trial显示文摘 | Gheorghiade M Gattis WA O′Connor CM | | 0，，16： | 1 |
| 8 | Implications of elevated cardiac Iroponin T in ambulatory patients with heart failure: a prospective analysis显示文摘 | Hudson MP O'Connor CM Gattis WA | 2004 | Am Heart J2004，147，： | 1 |
| 9 | Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure:Insights from the flolan international randomized survival trial(FIRST)显示文摘 | Gattis WA Uretshy BF | 1999 | Am Heart J1999，138，1： | 1 |
| 10 | Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized vdth worsening heart failure: a randomized controlled trial显示文摘 | Gheorghiade M Gattis WA O' Connor CM | 2004 | JAMA2004，291，16： | 1 |
| 11 | Effects of tolvaptan,a vasopressin antagonist,in patients hospitalizd with worsening heart failure: a randomized controlled trial 显示文摘 | Gheorghiade M Gattis WA O' Connor GM | 2004 | JAMA2004，291，16： | 1 |
| 12 | Effects of tovaptan,a vasopressin antagonist,in patients hospitalized with worsening heart failure:a randomized controlled trial显示文摘 | Gheorghiade M Gattis WA O'connor CM | 2004 | JAMA2004，291，16： | 1 |
| 13 | Tezosentan in patients with acute heart failure and acute coronary syndromes:results of the randomized intravenous tezosentan study(RITZ-4)显示文摘 | O'Connor CM Gattis WA Adams KF | 2003 | J Am Coll Cardiol2003，41，9： | 1 |
| 14 | Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure:insights from the ~olan International Randomized Survival Trial (FIRST) 显示文摘 | O' Connor CM Gattis WA Uretsky BF | 1999 | Am Heart J1999，138，： | 1 |
| 15 | Pharmacologic therapy for pateins with chronic heart failure and reduces systolic function review of trials and practical considerations显示文摘 | Klein L Connor CM Gattis WA | 2003 | Am J Cardiol2003，91，9： | 1 |
| 16 | Usefulness of an elevated troponin-Ⅰ in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome(from the RITZ -4 trial)显示文摘 | Gattis WA O'Connor CM Hasselblad V | 2004 | Am J Cardiol2004，93，11： | 1 |
| 17 | Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function显示文摘 | O'Connor CM Gattis WA Shaw L | 2000 | Am J Cardiol2000，86，8： | 1 |
| 18 | Synthesis and biological evaluation of 5-methylene]oxazoles,and-imidazoles:novel dual 5-lipoxygenase and cyclooxygenase inhibitors with anti in flam matory activity显示文摘 | Unangst PC Connor DT Cetenko WA | 1994 | J Med Chem1994，37，2： | 1 |
| 19 | Predictors of mortality in patients hospitalized with worsening heart failure:insight from the ACTIV in CHF trial显示文摘 | O′Connor CM Adams KF Gattis WA | 2005 | J Am Coll Cardiol2005，，： | 1 |
| 20 | Effects of tolvaptan, a vasopressin antagonist, in patients hospitslized with worsening heart failure: a randomized controlled trial显示文摘 | GHEORGHIADE M GATTIS WA O'CONNOR CM | 2004 | JAMA2004，291，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员